fixyruw.wordpress.com
Hematide is in a Phase III Renton led Onyx for nearly 15 stepping down in Februaryt 2008as president, CEO, chairman and a member of Onyx’s board. At the he helped negotiate a research, developmenr and commercialization partnership with that resultex inthe anti-cancer drug Nexavar. Nexavart tablets, which cost aboutf $5,000 a month in the United States and areapproachinf $1 billion in annual are approved in more than 80 countries to treart kidney cancer and 70-plus countries for liver Prior to joining Onyx, Renton was presiden and COO of Chiron, whicnh acquired Cetus in 1991. Renton had been presidentt of Cetussince 1990, COO since 1987 and CFO from 1983 to 1987.
Rentojn also serves on the boardsof , Cepheir and the Special Olympics of Northern
ไม่มีความคิดเห็น:
แสดงความคิดเห็น